Fatal liver failure after therapeutic doses of paracetamol in a patient with Duchenne muscular dystrophy and atypical pharmacogenetic profile of drug‐metabolizing enzymes-Reference-Cited by-同舟云学术

Fatal liver failure after therapeutic doses of paracetamol in a patient with Duchenne muscular dystrophy and atypical pharmacogenetic profile of drug‐metabolizing enzymes

Published:2020-02-05 Issue:1 Volume:127 Page:47-51
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Lao Yvonne Elisabeth¹^ORCID,Molden Espen²,Kringen Marianne Kristiansen²³,Annexstad Ellen Johanne⁴^ORCID,Sæverud Håvard Andreassen⁵^ORCID,Jacobsen Dag⁶⁷,Hovda Knut Erik¹

Affiliation:

1. Norwegian National Unit for CBRNE Medicine Department of Acute Medicine Oslo University Hospital Oslo Norway

2. Center for Psychopharmacology Diakonhjemmet Hospital Oslo Norway

3. Department of Life Sciences and Health Oslo Metropolitan University Oslo Norway

4. Department of Neurology Unit for Congenital and Inherited Neuromuscular Disorders Oslo University Hospital Oslo Norway

5. Department of Pulmonology Oslo University Hospital Oslo Norway

6. Department of Acute Medicine Oslo University Hospital Oslo Norway

7. Faculty of Medicine Institute of Clinical Medicine University of Oslo Oslo Norway

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13389

Reference26 articles.

1. Exploring Chronic Pain in Youths with Duchenne Muscular Dystrophy: A Model for Pediatric Neuromuscular Disease

2. Neuromuscular disorders: genes, genetic counseling and therapeutic trials

3. Chronic Pain in Persons With Neuromuscular Disease

4. Pain in Youths With Neuromuscular Disease

5. Pain in adolescents with spinal muscular atrophy and Duchenne and Becker muscular dystrophy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is There a Causal Connection? Mendelian Randomization Analysis of Muscular Dystrophies and Non-Alcoholic Fatty Liver Diseases;2024-02-05

2. Acetaminophen treatment in children and adults with spinal muscular atrophy: a lower tolerance and higher risk of hepatotoxicity;Neuromuscular Disorders;2024-01

3. Evaluation of the Association between Single Nucleotide Polymorphisms of Metabolizing Enzymes with the Serum Concentration of Paracetamol and Its Metabolites;Metabolites;2022-12-09

4. Hepatoprotective potential of isolated flavonoids from Trapa natans L. against the paracetamol induced oxidative stress in rats;Indian Journal of Experimental Biology;2022-12-01

5. miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy;Scientific Reports;2022-03-10